全文获取类型
收费全文 | 63篇 |
免费 | 1篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 2篇 |
基础医学 | 10篇 |
口腔科学 | 1篇 |
临床医学 | 10篇 |
内科学 | 7篇 |
神经病学 | 1篇 |
特种医学 | 1篇 |
外科学 | 2篇 |
预防医学 | 8篇 |
眼科学 | 1篇 |
药学 | 18篇 |
肿瘤学 | 2篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 4篇 |
2020年 | 1篇 |
2018年 | 1篇 |
2016年 | 3篇 |
2015年 | 3篇 |
2014年 | 2篇 |
2013年 | 3篇 |
2012年 | 7篇 |
2011年 | 9篇 |
2010年 | 1篇 |
2009年 | 2篇 |
2008年 | 7篇 |
2007年 | 2篇 |
2006年 | 1篇 |
2005年 | 3篇 |
2004年 | 1篇 |
2003年 | 3篇 |
2002年 | 1篇 |
2001年 | 1篇 |
2000年 | 2篇 |
1997年 | 1篇 |
1994年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有64条查询结果,搜索用时 15 毫秒
61.
Absorption and cleavage of enalapril,a carboxyl ester prodrug,in the rat intestine: in vitro,in situ intestinal perfusion and portal vein cannulation models
下载免费PDF全文
![点击此处可从《Biopharmaceutics & drug disposition》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Vinay K. Holenarsipur Nilesh Gaud Jaydeep Sinha Sankara Sivaprasad Priyadeep Bhutani Murali Subramanian Sheelendra Pratap Singh Rambabu Arla Sundeep Paruchury Tarun Sharma Punit Marathe Sandhya Mandlekar 《Biopharmaceutics & drug disposition》2015,36(6):385-397
In recent years prodrug strategy has been used extensively to improve the pharmacokinetic properties of compounds exhibiting poor bioavailability. Mechanistic understanding of the absorption and the role of intestine and liver in the activation of oral prodrugs is crucial. Enalapril, a carboxyl ester prodrug, is reported to be metabolized by human carboxylesterase‐1 (CES1) but not by carboxylesterase‐2 (CES2) to its active metabolite enalaprilat. Further, it has been reported that the small intestines of both rat and human contain mainly CES2. The objective of this work was to understand whether enalapril remains unchanged as it is absorbed through the intestine into the portal circulation. This was evaluated using different intestinal preparations, an in situ intestinal perfusion experiment and a portal vein cannulated rat model. No turnover of enalapril was seen with commercial rat intestinal S9 and microsomes, but reasonable turnover was observed with freshly prepared rat intestinal and mucosal homogenate and S9. In the intestinal perfusion study, both enalapril and enalaprilat were observed in the mesenteric plasma with the data suggesting 32% hydrolysis of enalapril in the intestine. In the portal vein cannulated rat, about 51% of enalapril absorbed into intestine was converted to enalaprilat. Overall, it was demonstrated that even though enalapril has been shown to be a specific substrate for CES1, it is converted to enalaprilat to a significant extent in the intestine. Such experimental techniques can be applied by other scientific groups who are working on prodrugs to determine the region and extent of activation. Copyright © 2015 John Wiley & Sons, Ltd. 相似文献
62.
Gundla R Kazemi R Sanam R Muttineni R Sarma JA Dayam R Neamati N 《Journal of medicinal chemistry》2008,51(12):3367-3377
Consensus virtual screening models were generated and validated utilizing a set of known human epidermal growth factor receptor-2 (HER2) inhibitors and modeled HER2 active and inactive state structures. The virtual screening models were successfully employed to discover a set of structurally diverse compounds with growth inhibitory activity against HER2-overexpressing SKBR3 breast cancer cell line. A search of a 3D database containing 350000 small-molecules using the consensus models retrieved 531 potential hits. Of the 531 hits, 57 were selected for testing in SKBR3 cells on the basis of structural novelty and desirable drug-like properties. Seven compounds inhibited growth of SKBR3 cells with IC50 values <10 microM. These lead compounds have desirable physicochemical properties and are excellent candidates for further optimization. 相似文献
63.
Timur Liwinski Sina Hübener Lara Henze Peter Hübener Melina Heinemann Marcus Tetzlaff Marie I. Hiller Bettina Jagemann Rambabu Surabattula Diana Leeming Morten Karsdal Erika Monguzzi Guido Schachschal Thomas Rösch Corinna Bang Andre Franke Ansgar W. Lohse Detlef Schuppan Christoph Schramm 《Alimentary pharmacology & therapeutics》2023,57(2):224-236